Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR)

Historical Holders from Q4 2015 to Q1 2025

Symbol
VYGR on Nasdaq
CUSIP
92915B106
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
54.6M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
34.5M
Holdings value
$196M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
129
Number of buys
61
Number of sells
-54
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 9.88% $18.2M 5.4M Armistice Capital, LLC Dec 31, 2024

Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 195K $658K -$41.3K $3.38 6
2024 Q4 34.5M $196M -$3.24M $5.67 129
2024 Q3 35M $205M -$20.2M $5.85 126
2024 Q2 38.1M $302M +$18.9M $7.91 126
2024 Q1 35.6M $331M +$80.2M $9.31 132
2023 Q4 25.9M $219M -$3.13M $8.44 106
2023 Q3 26.2M $203M +$537K $7.75 110
2023 Q2 25.6M $293M +$48.1M $11.45 104
2023 Q1 22.7M $175M -$218K $7.71 80
2022 Q4 22.7M $139M -$504K $6.10 66
2022 Q3 22.7M $134M -$774K $5.92 65
2022 Q2 22.8M $135M +$8.69M $5.91 71
2022 Q1 21.2M $162M +$28.9M $7.62 65
2021 Q4 17.5M $47.5M -$8.94M $2.71 46
2021 Q3 21.3M $56.1M -$4.25M $2.63 63
2021 Q2 21.9M $90.6M -$15.6M $4.13 69
2021 Q1 25.6M $121M -$5.4M $4.71 89
2020 Q4 27.2M $194M -$5M $7.15 91
2020 Q3 27.7M $296M -$21.2M $10.67 105
2020 Q2 29.2M $369M -$4.47M $12.62 103
2020 Q1 29M $265M -$11.9M $9.15 111
2019 Q4 30.4M $423M -$7.29M $13.95 130
2019 Q3 30.4M $523M +$3.4M $17.21 124
2019 Q2 29M $788M +$142M $27.22 122
2019 Q1 27.2M $520M +$3.58M $19.14 106
2018 Q4 27.8M $261M -$17M $9.40 111
2018 Q3 28.9M $547M -$4.06M $18.92 115
2018 Q2 29.1M $569M +$41.4M $19.54 124
2018 Q1 27.1M $509M +$37M $18.79 106
2017 Q4 25.2M $418M +$68.4M $16.60 97
2017 Q3 11.3M $233M +$24.1M $20.59 74
2017 Q2 10.9M $98.1M -$1.7M $8.96 51
2017 Q1 11.1M $146M +$8.71M $13.24 45
2016 Q4 11M $140M +$4.08M $12.74 54
2016 Q3 10.6M $128M +$782K $12.01 50
2016 Q2 10.6M $116M +$5.97M $10.99 48
2016 Q1 10M $87M -$3.38M $8.73 41
2015 Q4 10.4M $225M +$220M $21.90 34